Search for: "Price v. Cross"
Results 81 - 100
of 1,755
Sort by Relevance
|
Sort by Date
24 Aug 2023, 9:05 pm
DAOs enable transparent pricing mechanisms and cost optimization strategies. [read post]
21 Aug 2023, 4:34 am
Franklin v Hafftka, 140 AD3d 922, 924). [read post]
20 Aug 2023, 9:05 pm
Fang, V. [read post]
16 Aug 2023, 5:03 am
" Thereafter, the price goes up to $32. [read post]
14 Aug 2023, 4:30 am
For South Africa, cases examined are: Soobramoney v Minister of Health; Minister of Health & Ors v Treatment Action Campaign & Others (No. 2); and Minister of Health v New Clicks, which deal with the interpretation and effect of constitutional provisions on the right of access to health care services; and Pfizer v Cipla MedPro; and Aventis v Cipla, which deal with the tension between patent rights and the right to health.However, in the judicial… [read post]
8 Aug 2023, 9:05 pm
Tørsløv, T. [read post]
7 Aug 2023, 9:12 pm
In Brown Shoe v. [read post]
6 Aug 2023, 10:00 pm
My guess is that the CJEU, under the guise of aiding harmonization, has crossed the line from being honest interpreters of EU directives and lapsed into the role of policy maker. [read post]
31 Jul 2023, 5:04 pm
The post Case Review – Built By Engineers v. [read post]
28 Jul 2023, 9:11 am
¶¶ 148–49; accord Friel v. [read post]
28 Jul 2023, 6:43 am
Darrow JJ, Van de Wiele V, Beran D, Kesselheim AS. [read post]
24 Jul 2023, 3:59 pm
[54] New Classic Cases – Falstaff The new Guidelines cite U.S. v. [read post]
24 Jul 2023, 4:14 am
” Section 1, in turn, specifies a price of $100, payable within six months. [read post]
23 Jul 2023, 9:01 pm
Although the draft Merger Guidelines provide a litany of examples of mechanisms that might give rise to entrenchment concerns, they stop short of identifying when a deal crosses the line. [read post]
17 Jul 2023, 9:05 pm
However, price data[3] from coinmarketcap.com show that XRP is too volatile to reliably serve as a store of value and is likely to be purchased primarily for speculative purposes: The opinion identifies SEC v. [read post]
14 Jul 2023, 1:22 pm
In addition, the Judge noticed that the deal plan evaluation model presented to the Microsoft Board of Directors to justify the Activision purchase price (iv) relied on PlayStation sales and other non-Microsoft platforms post-acquisition, and (v) reflected access to mobile content as a critical factor in favor of the deal. [read post]
10 Jul 2023, 1:58 am
Leonid V. [read post]
10 Jul 2023, 1:58 am
Leonid V. [read post]
6 Jul 2023, 8:03 am
That also applies to merchandise quality, on time delivery, price, and other elements of the deal. [read post]
6 Jul 2023, 2:55 am
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
